Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01682694 · ClinicalTrials.gov registry record · NA
Glucosamine and Chondroitin Effects
A NA study of Inflammation, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01682694: Completed NA study of Inflammation, sponsored by Fred Hutchinson Cancer Center.
NCT01682694 is a NA study of Inflammation that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 20 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01682694, a NA study of Inflammation, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
A common starting dose of glucosamine and chondroitin will reduce inflammation as reflected by a reduction in serum C-reactive protein.
Primary Outcome
hsCRP is a biomarker of systemic inflammation
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT placebo
- DIETARY_SUPPLEMENT Glucosamine and Chondroitin
Study Locations (1)
Washington
- Fred Hutchinson Cancer Research Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-09 |
| Est. Completion | 2013-08 |
| Phase | NA |
What the finished NCT01682694 record still lists
NCT01682694 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Inflammation appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT01682694 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT01682694 about?
NCT01682694 is a clinical study titled "Glucosamine and Chondroitin Effects". A common starting dose of glucosamine and chondroitin will reduce inflammation as reflected by a reduction in serum C-reactive protein.
What is the current status of trial NCT01682694?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2012-09. Estimated completion is 2013-08.
What conditions does trial NCT01682694 study?
This clinical trial studies the following conditions: Inflammation.
What interventions are being tested in trial NCT01682694?
The interventions under investigation include: placebo (DIETARY_SUPPLEMENT), Glucosamine and Chondroitin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01682694?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01682694 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01682694's enrollment target sits among peer trials
20 119th of 132 higher than 11 of 132 other Inflammation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Inflammation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
RECRUITING · NA
-
Evaluating Whether Hyperbaric Oxygen Therapy Can Improve VO₂-Max and Reduce Inflammation Markers in Healthy Adults Ages 30-60.
RECRUITING · NA
-
Impact of NMES and HPRO on Recovery After SAH- Pilot Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia